ArticleMolecular neurobiology2023

TR-FRET-Based Immunoassay to Measure Ataxin-2 as a Target Engagement Marker in Spinocerebellar Ataxia Type 2.

Jessica Bux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.